Chern‐En Chiang

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi et al. · New England Journal of Medicine · 2019 · 6.9K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Brian Claggett et al. · New England Journal of Medicine · 2022 · 2.7K citations · Full text

Medicine, Cardiology, Pharmacology +17

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Jan Steffel, Peter Verhamme, Tatjana Potpara et al. · European Heart Journal · 2018 · 2.1K citations · Full text

Medicine, Cardiology, Pharmacotherapy +11

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Muthiah Vaduganathan et al. · New England Journal of Medicine · 2024 · 709 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17